Literature DB >> 6102839

Interaction of clonidine and beta-blockers.

M Lilja, A J Jounela, H Juustila, M J Mattila.   

Abstract

On the hypothesis that non-selective beta-blockers can antagonize or reverse the antihypertensive effect of clonidine (C), 12 hypertensive outpatients were treated with C alone and in combination with propranolol (P), atenolol (A) and prazosin (Pz). C alone (0.11 or 0.22 mg b.i.d.) or in combination with P (80 mg b.i.d.) did not provide normotension. Changing P to A (50 mg b.i.d.) reduced supine systolic and diastolic pressures, which now were significantly lower (p less than 0.01) than during C alone. Changing A to P again resulted in elevated pressures. Pz (1 mg t.i.d.) added to the C+P regimen lowered supine blood pressures to the levels otherwise recorded during C+A. C dose-dependently contracted rabbit aortic spiral in vitro, reaching about 50% of maximum responses to noradrenaline. Pz abolished this response. P (0.1--10 micrograms/ml) but not A somewhat enhanced responses to high doses of C. Sotalol rather antagonized C contractions. We conclude that A but not P enhances the antihypertensive action of C. No hypertensive interaction was observed.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6102839     DOI: 10.1111/j.0954-6820.1980.tb09700.x

Source DB:  PubMed          Journal:  Acta Med Scand        ISSN: 0001-6101


  3 in total

Review 1.  [Strategies for perioperative sympatho-modulation].

Authors:  J Wacker; T Pasch; M C Schaub; M Zaugg
Journal:  Anaesthesist       Date:  2005-04       Impact factor: 1.041

Review 2.  Possible indications of beta-blockers in the perioperative period other than prevention of cardiac ischemia.

Authors:  Yuji Kadoi; Shigeru Saito
Journal:  J Anesth       Date:  2010-02       Impact factor: 2.078

3.  Long-term experience with the combination of clonidine and beta-adrenoceptor blocking agents in hypertension.

Authors:  R Vanholder; N Lameire; S Ringoir
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.